Detalles de la búsqueda
1.
Benefit-risk profile of extended dual antiplatelet therapy beyond 1 year in patients with high risk of ischemic or bleeding events after PCI.
Platelets
; 32(4): 533-541, 2021 May 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-32498587
2.
Association of lipoprotein(a) with platelet aggregation and thrombogenicity in patients undergoing percutaneous coronary intervention.
Platelets
; 32(5): 684-689, 2021 Jul 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32787598
3.
Percutaneous Coronary Intervention Complexity and Risk of Adverse Events in relation to High Bleeding Risk among Patients Receiving Drug-Eluting Stents: Insights from a Large Single-Center Cohort Study.
J Interv Cardiol
; 2020: 2985435, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32405273
4.
Two-Year Outcomes after Left Main Coronary Artery Percutaneous Coronary Intervention in Patients Presenting with Acute Coronary Syndrome.
J Interv Cardiol
; 2020: 6980324, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32327944
5.
Apolipoprotein B/A-I Ratio Predicts Lesion Severity and Clinical Outcomes in Diabetic Patients With Acute Coronary Syndrome.
Circ J
; 84(7): 1132-1139, 2020 06 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-32418956
6.
Benefit-Risk Profile of DAPT Continuation Beyond 1 Year after PCI in Patients with High Thrombotic Risk Features as Endorsed by 2018 ESC/EACTS Myocardial Revascularization Guideline.
Cardiovasc Drugs Ther
; 34(5): 663-675, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32601780
7.
Contribution of ESC DAPT guideline-endorsed high thrombotic risk features to long-term clinical outcomes among patients with and without high bleeding risk after PCI.
BMC Cardiovasc Disord
; 20(1): 313, 2020 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32611318
8.
Lipoprotein(a) levels are associated with coronary severity but not with outcomes in Chinese patients underwent percutaneous coronary intervention.
Nutr Metab Cardiovasc Dis
; 30(2): 265-273, 2020 02 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31740238
9.
Effect of prior stroke on long-term outcomes of percutaneous coronary interventions in Chinese patients: A large single-center study.
Catheter Cardiovasc Interv
; 93(2): E75-E80, 2019 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30421857
10.
Platelet reactivity in patients with chronic kidney disease undergoing percutaneous coronary intervention.
Platelets
; 30(7): 901-907, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30518271
11.
Guideline for [Clinical Guidelines Constitution/Amendment] in China.
Int J Qual Health Care
; 31(7): 568-574, 2019 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30388240
12.
Biodegradable polymer drug-eluting stents versus second-generation drug-eluting stents in patients with and without diabetes mellitus: a single-center study.
Cardiovasc Diabetol
; 17(1): 114, 2018 08 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-30107794
13.
Clinical outcomes and influencing factors of in-stent restenosis after stenting for symptomatic stenosis of the vertebral V1 segment.
J Vasc Surg
; 68(5): 1406-1413, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29789215
14.
Predictive value of neutrophil to lymphocyte ratio in long-term outcomes of left main and/or three-vessel disease in patients with acute myocardial infarction.
Catheter Cardiovasc Interv
; 91(S1): 551-557, 2018 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29330938
15.
Dual antiplatelet therapy after coronary drug-eluting stent implantation in China: A large single center study.
Catheter Cardiovasc Interv
; 91(S1): 566-572, 2018 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29359390
16.
Sex-based differences in bleeding and long-term adverse events after percutaneous coronary intervention in older patients with coronary artery disease.
J Interv Cardiol
; 31(3): 345-352, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29490431
17.
Effect of sex difference in clinical presentation (stable coronary artery disease vs unstable angina pectoris or non-ST-elevation myocardial infarction vs ST-elevation myocardial infarction) on 2-year outcomes in patients undergoing percutaneous coronary intervention.
J Interv Cardiol
; 31(1): 5-14, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29023996
18.
Association of CDKN2B-AS1 Polymorphisms with Premature Triple-vessel Coronary Disease and Their Sex Specificity in the Chinese Population.
Biomed Environ Sci
; 31(11): 787-796, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-30558699
19.
Prognostic Value of NT-proBNP in Stable Coronary Artery Disease in Chinese Patients after Percutaneous Coronary Intervention in the Drug-eluting Stent Era.
Biomed Environ Sci
; 31(12): 859-866, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30636655
20.
Effect of coronary dominance on 2-year outcomes after percutaneous coronary intervention in patients with acute coronary syndrome.
Catheter Cardiovasc Interv
; 89(S1): 549-554, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-28318135